Business Context and Reporting Period
This Form 8-K is a current report filed by Inpixon (trading symbol: INPX) on June 16, 2023, with events reported as of June 20, 2023. The company is incorporated in Nevada and its common stock is listed on The Nasdaq Capital Market. The filing details the entry into a material definitive agreement regarding warrant amendments and the unregistered sale of equity securities.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. However, it discloses specific capital structure updates:
- Debt Reduction: The company reduced the outstanding balance of a promissory note issued on July 22, 2022, by approximately $400,000.
- Equity Issuance: The company issued 1,995,573 shares of Common Stock to settle the aforementioned debt.
- Issuance Price: Shares were issued at a price between $0.195 and $0.2062 per share, adhering to the Nasdaq Listing Rule 5635(d) Minimum Price.
- Outstanding Shares: As of June 21, 2023, the company had 40,296,799 shares of Common Stock outstanding.
Material Changes and Agreements
The filing reports two primary material changes:
- Warrant Amendment (Item 1.01): On June 20, 2023, Inpixon amended its Warrant Purchase Agreement and Warrants issued on May 17, 2023. Key changes include:
- Granting holders the right to participate in up to 20% of subsequent equity financings on a pro-rata basis for 12 months.
- Extending the deadline to file a registration statement for warrant shares from 30 to 45 days.
- Establishing a floor price of $0.10 for the Adjusted Exercise Price.
- Limiting circumstances for exercise price adjustments and removing certain rights regarding future rights offerings.
- Debt-for-Equity Exchange (Item 3.02): The company executed Exchange Agreements to partition and exchange approximately $400,000 of outstanding promissory notes for common stock. This transaction was exempt from registration under Section 3(a)(9) of the Securities Act.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal disclosures regarding the amendment terms and the reliance on registration exemptions. The amendment includes provisions requiring the company to use commercially reasonable efforts to file registration statements and to register remaining shares if SEC staff limitations under Rule 415 apply.
Investor Verification Checklist
- Verify the impact of the new 20% participation right on future dilution in potential equity financings.
- Confirm the status of the registration statement for the warrant shares, noting the extended 45-day filing window.
- Review the full text of the Amendment Agreement (Exhibit 10.1) for detailed terms on exercise price adjustments and the $0.10 floor.
- Assess the remaining balance of the July 2022 Note and other outstanding debt obligations post-exchange.